首页 > 最新文献

Journal of Urology最新文献

英文 中文
PROSTATE SIZE AND ITS EFFECT ON LUTS/BPH IMPROVEMENT FOLLOWING CONVECTIVE WATER VAPOR THERMAL THERAPY.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1097/JU.0000000000004516
Owen Lewer, Michael D Felice, Olivia Copelan, Sarang Janakiraman, Gaurav Pahouja, Amy Wozniak, Kevin T McVary

Purpose: Lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) affects quality of life. Convective water vapor thermal therapy (CWVTT - Rezum) is a minimally invasive surgical treatment for LUTS/BPH which produces significant improvement of LUTS in men with prostates between 30cc-80 cc with minimal de-novo sexual dysfunction. However, outcomes across the prostate volume (PV) spectrum are incompletely described. We aim to elucidate the relationship between PV and outcomes post-CWVTT in men with LUTS/BPH.

Materials and methods: Patients undergoing CWVTT at a tertiary care center were included. The primary outcome was change in IPSS pre-CWVTT compared post-CWVTT between PV tertiles - small (≤38.5 cc), medium (38.5 - ≤55.6cc), and large (>55.6cc). Secondary outcome was time to a minimally clinically important difference (MCID) of 25% decrease in IPSS.

Results: 171 patients were divided into small (n=56), medium (n=54), and large (n=61) PV tertiles. The change in IPSS pre-operatively to 3-months was significant for all tertiles with mean difference of [-7.51 (-10.14, -4.83)], [-10.12 (-12.71, -7.53)], and [-11.72 (-14.14, -9.29)] for small, medium, and large PV, respectively (p=<0.001). In multivariable analysis, having diabetes was associated with increased IPSS after 3mo with average increase (95% CI) of [3.67 (0.23,7.11), p=0.037] compared to not having diabetes The median time (Q1, Q3) to -25% in IPSS for small, medium, and large PV were 16.1 (12.1, 17.5), 12.3 (7.1, 15.7), and 13.8 (10.8, 16.3) months, respectively. In multivariable analysis, medium PV had significantly increased incidence of 25% decrease compared to small PV [HR (95%CI): 2.10 (1.19, 3.72), p=0.011].

Conclusions: CWVTT results in significant and durable LUTS improvement across the prostate volume spectrum. All prostate volumes experience the same improvement in LUTS post-CWVTT. However, medium and large glands may improve more quickly than small glands.

{"title":"PROSTATE SIZE AND ITS EFFECT ON LUTS/BPH IMPROVEMENT FOLLOWING CONVECTIVE WATER VAPOR THERMAL THERAPY.","authors":"Owen Lewer, Michael D Felice, Olivia Copelan, Sarang Janakiraman, Gaurav Pahouja, Amy Wozniak, Kevin T McVary","doi":"10.1097/JU.0000000000004516","DOIUrl":"10.1097/JU.0000000000004516","url":null,"abstract":"<p><strong>Purpose: </strong>Lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) affects quality of life. Convective water vapor thermal therapy (CWVTT - Rezum) is a minimally invasive surgical treatment for LUTS/BPH which produces significant improvement of LUTS in men with prostates between 30cc-80 cc with minimal de-novo sexual dysfunction. However, outcomes across the prostate volume (PV) spectrum are incompletely described. We aim to elucidate the relationship between PV and outcomes post-CWVTT in men with LUTS/BPH.</p><p><strong>Materials and methods: </strong>Patients undergoing CWVTT at a tertiary care center were included. The primary outcome was change in IPSS pre-CWVTT compared post-CWVTT between PV tertiles - small (≤38.5 cc), medium (38.5 - ≤55.6cc), and large (>55.6cc). Secondary outcome was time to a minimally clinically important difference (MCID) of 25% decrease in IPSS.</p><p><strong>Results: </strong>171 patients were divided into small (n=56), medium (n=54), and large (n=61) PV tertiles. The change in IPSS pre-operatively to 3-months was significant for all tertiles with mean difference of [-7.51 (-10.14, -4.83)], [-10.12 (-12.71, -7.53)], and [-11.72 (-14.14, -9.29)] for small, medium, and large PV, respectively (p=<0.001). In multivariable analysis, having diabetes was associated with increased IPSS after 3mo with average increase (95% CI) of [3.67 (0.23,7.11), p=0.037] compared to not having diabetes The median time (Q1, Q3) to -25% in IPSS for small, medium, and large PV were 16.1 (12.1, 17.5), 12.3 (7.1, 15.7), and 13.8 (10.8, 16.3) months, respectively. In multivariable analysis, medium PV had significantly increased incidence of 25% decrease compared to small PV [HR (95%CI): 2.10 (1.19, 3.72), p=0.011].</p><p><strong>Conclusions: </strong>CWVTT results in significant and durable LUTS improvement across the prostate volume spectrum. All prostate volumes experience the same improvement in LUTS post-CWVTT. However, medium and large glands may improve more quickly than small glands.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004516"},"PeriodicalIF":5.9,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: Time to Change Our Mindset! Integrating Sustainability Into Urological Practice.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1097/JU.0000000000004485
María Paula Herrera, Juan Carlos Velez
{"title":"Letter: Time to Change Our Mindset! Integrating Sustainability Into Urological Practice.","authors":"María Paula Herrera, Juan Carlos Velez","doi":"10.1097/JU.0000000000004485","DOIUrl":"https://doi.org/10.1097/JU.0000000000004485","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004485"},"PeriodicalIF":5.9,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143557219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1097/JU.0000000000004493
Alireza Ghoreifi
{"title":"Editorial Comment.","authors":"Alireza Ghoreifi","doi":"10.1097/JU.0000000000004493","DOIUrl":"https://doi.org/10.1097/JU.0000000000004493","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004493"},"PeriodicalIF":5.9,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-05 DOI: 10.1097/JU.0000000000004487
Sohei Kuribayashi, Scott D Lundy
{"title":"Editorial Comment.","authors":"Sohei Kuribayashi, Scott D Lundy","doi":"10.1097/JU.0000000000004487","DOIUrl":"https://doi.org/10.1097/JU.0000000000004487","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004487"},"PeriodicalIF":5.9,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-04 DOI: 10.1097/JU.0000000000004488
Lynn Stothers
{"title":"Editorial Comment.","authors":"Lynn Stothers","doi":"10.1097/JU.0000000000004488","DOIUrl":"https://doi.org/10.1097/JU.0000000000004488","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004488"},"PeriodicalIF":5.9,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-04 DOI: 10.1097/JU.0000000000004492
Axel Heidenreich
{"title":"Editorial Comment.","authors":"Axel Heidenreich","doi":"10.1097/JU.0000000000004492","DOIUrl":"10.1097/JU.0000000000004492","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004492"},"PeriodicalIF":5.9,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized controlled trial of ultrasonic propulsion-facilitated clearance of residual renal stone fragments versus observation.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-03 DOI: 10.1097/JU.0000000000004501
Claire C Yang, Elizabeth E Keating, Ravi Managuli, Nancy Honssinger, Sarah K Holt, Alana C Desai

Purpose: In patients with residual stone fragments, ultrasonic propulsion (UP) increased fragment passage rate by 58% and reduced risk of relapse by 70% vs. untreated controls with minor associated adverse events. This study presents a second, independent trial of UP to demonstrate replication of those results and effective training of a novice team of users.

Materials and methods: This was a multi-center, prospective, open label, randomized, controlled trial. Adults with residual fragments ≤ 5 mm seen on clinical imaging at least 4 weeks post-lithotripsy were enrolled. The treatment group underwent UP; the control group did not. The effectiveness endpoints included the proportion of subjects reporting visual observation of stone passage within 3 weeks post-procedure (treatment group) or randomization (controls) and the reduction in stone burden on follow-up imaging captured within 90 days post-procedure/randomization. The safety endpoints were adverse events (AEs) within 3 weeks post-procedure/randomization. Fisher's Exact test was used for comparison.

Results: The trial was conducted April - October 2024. Fragments remained a median of 6 months after surgery before study enrollment. Ten of 12 treated participants passed fragments vs. 2 of 12 controls (P=0.003). Nine of 12 treated participants saw stone burden reduction on imaging vs. 1 of 11 controls (P=0.003). All AEs were mild, occurring in 7 of 12 treated participants and 4 of 12 controls.

Conclusions: Consistent with the index study, UP conducted by an independent group of operators demonstrated a higher rate of fragment passage and greater reduction in stone burden following UP compared to controls, with minor associated risk.

{"title":"A randomized controlled trial of ultrasonic propulsion-facilitated clearance of residual renal stone fragments versus observation.","authors":"Claire C Yang, Elizabeth E Keating, Ravi Managuli, Nancy Honssinger, Sarah K Holt, Alana C Desai","doi":"10.1097/JU.0000000000004501","DOIUrl":"https://doi.org/10.1097/JU.0000000000004501","url":null,"abstract":"<p><strong>Purpose: </strong>In patients with residual stone fragments, ultrasonic propulsion (UP) increased fragment passage rate by 58% and reduced risk of relapse by 70% vs. untreated controls with minor associated adverse events. This study presents a second, independent trial of UP to demonstrate replication of those results and effective training of a novice team of users.</p><p><strong>Materials and methods: </strong>This was a multi-center, prospective, open label, randomized, controlled trial. Adults with residual fragments ≤ 5 mm seen on clinical imaging at least 4 weeks post-lithotripsy were enrolled. The treatment group underwent UP; the control group did not. The effectiveness endpoints included the proportion of subjects reporting visual observation of stone passage within 3 weeks post-procedure (treatment group) or randomization (controls) and the reduction in stone burden on follow-up imaging captured within 90 days post-procedure/randomization. The safety endpoints were adverse events (AEs) within 3 weeks post-procedure/randomization. Fisher's Exact test was used for comparison.</p><p><strong>Results: </strong>The trial was conducted April - October 2024. Fragments remained a median of 6 months after surgery before study enrollment. Ten of 12 treated participants passed fragments vs. 2 of 12 controls (P=0.003). Nine of 12 treated participants saw stone burden reduction on imaging vs. 1 of 11 controls (P=0.003). All AEs were mild, occurring in 7 of 12 treated participants and 4 of 12 controls.</p><p><strong>Conclusions: </strong>Consistent with the index study, UP conducted by an independent group of operators demonstrated a higher rate of fragment passage and greater reduction in stone burden following UP compared to controls, with minor associated risk.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004501"},"PeriodicalIF":5.9,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Excretory Phase Computerized Tomography Important for Evaluation of Pediatric High-Grade Renal Trauma?
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-03 DOI: 10.1097/JU.0000000000004515
Ching Man Carmen Tong, Luke Shumaker, Jacob Lucas, Vinaya Bhatia, Albert Lee, Benjamin Abelson, Gabriella L Crane, Christina Ho, Christopher J Long, Robert T Russell, Harold N Lovvorn, Ming-Hsien Wang, Dana A Weiss, Douglass B Clayton, David M Kitchens

Purpose: There are no standardized guidelines for evaluation of pediatric renal trauma. We hypothesize that screening radiographic studies performed to rule out traumatic renal injuries in children can initially be evaluated by contrast-enhanced CT scans that lack an excretory phase.

Materials and methods: We retrospectively collected data from five pediatric trauma centers between 2007-2020. Patients younger than 18 years old with renal trauma AAST grade 3 or higher were included. Outcomes data includes the rate for delayed surgical or radiologic interventions, complications, or readmissions related to the initial renal injuries.

Results: 351 children were included. 36% (127/351) had excretory-phase CT (EPCT) at initial evaluation. Median age was 13.6 (IQR 9.1-16.3) years. 56.7% (72/127) EPCT patients had grade IV/V injury vs. 53.6% (120/224) in NEPCT (p=0.3). 96% (338/351) were blunt injuries. NEPCT patients had higher median injury severity scores (21 vs. 16, p<0.01). EPCT children did not have more urinary drainage procedures (ureteral stent or percutaneous drain) (18% vs. 12%, p=0.11). Patients with initial NEPCT did not experience longer hospital stay (p=0.46), increased complications (p=0.52) or readmissions (p=0.54). Importantly, gross hematuria significantly predicted need for renal procedures (OR = 2.06, 95% CI 1.28-5.2, p < 0.001).

Conclusion: Patients with initial NEPCT did not experience increased adverse outcomes or readmission. Those presenting with gross hematuria had increased risk of higher-grade renal injury and need for renal procedure. This study suggests that high-grade pediatric renal trauma can be safely evaluated with NEPCT in initial trauma workup unless they present with gross hematuria.

{"title":"Is Excretory Phase Computerized Tomography Important for Evaluation of Pediatric High-Grade Renal Trauma?","authors":"Ching Man Carmen Tong, Luke Shumaker, Jacob Lucas, Vinaya Bhatia, Albert Lee, Benjamin Abelson, Gabriella L Crane, Christina Ho, Christopher J Long, Robert T Russell, Harold N Lovvorn, Ming-Hsien Wang, Dana A Weiss, Douglass B Clayton, David M Kitchens","doi":"10.1097/JU.0000000000004515","DOIUrl":"https://doi.org/10.1097/JU.0000000000004515","url":null,"abstract":"<p><strong>Purpose: </strong>There are no standardized guidelines for evaluation of pediatric renal trauma. We hypothesize that screening radiographic studies performed to rule out traumatic renal injuries in children can initially be evaluated by contrast-enhanced CT scans that lack an excretory phase.</p><p><strong>Materials and methods: </strong>We retrospectively collected data from five pediatric trauma centers between 2007-2020. Patients younger than 18 years old with renal trauma AAST grade 3 or higher were included. Outcomes data includes the rate for delayed surgical or radiologic interventions, complications, or readmissions related to the initial renal injuries.</p><p><strong>Results: </strong>351 children were included. 36% (127/351) had excretory-phase CT (EPCT) at initial evaluation. Median age was 13.6 (IQR 9.1-16.3) years. 56.7% (72/127) EPCT patients had grade IV/V injury vs. 53.6% (120/224) in NEPCT (p=0.3). 96% (338/351) were blunt injuries. NEPCT patients had higher median injury severity scores (21 vs. 16, p<0.01). EPCT children did not have more urinary drainage procedures (ureteral stent or percutaneous drain) (18% vs. 12%, p=0.11). Patients with initial NEPCT did not experience longer hospital stay (p=0.46), increased complications (p=0.52) or readmissions (p=0.54). Importantly, gross hematuria significantly predicted need for renal procedures (OR = 2.06, 95% CI 1.28-5.2, p < 0.001).</p><p><strong>Conclusion: </strong>Patients with initial NEPCT did not experience increased adverse outcomes or readmission. Those presenting with gross hematuria had increased risk of higher-grade renal injury and need for renal procedure. This study suggests that high-grade pediatric renal trauma can be safely evaluated with NEPCT in initial trauma workup unless they present with gross hematuria.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"101097JU0000000000004515"},"PeriodicalIF":5.9,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trauma, and Genital and Urethral Reconstruction.
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-20 DOI: 10.1097/JU.0000000000004323
Sean P Elliott
{"title":"Trauma, and Genital and Urethral Reconstruction.","authors":"Sean P Elliott","doi":"10.1097/JU.0000000000004323","DOIUrl":"https://doi.org/10.1097/JU.0000000000004323","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":"213 3","pages":"397-399"},"PeriodicalIF":5.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter: Generative Artificial Intelligence Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment. 信:生成式人工智能平台自动化社交媒体帖子来自泌尿外科杂志文章:横断面研究和随机评估。
IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-02 DOI: 10.1097/JU.0000000000004395
Lorenzo Storino Ramacciotti, Inderbir S Gill, Giovanni E Cacciamani
{"title":"Letter: Generative Artificial Intelligence Platform for Automating Social Media Posts From Urology Journal Articles: A Cross-Sectional Study and Randomized Assessment.","authors":"Lorenzo Storino Ramacciotti, Inderbir S Gill, Giovanni E Cacciamani","doi":"10.1097/JU.0000000000004395","DOIUrl":"10.1097/JU.0000000000004395","url":null,"abstract":"","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"380-381"},"PeriodicalIF":5.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1